Literature DB >> 16797731

Finnish adenoidectomy and tympanostomy rates in children; national variation.

Johanna Haapkylä1, Gunnhild Karevold, Kari Jorunn Kvaerner, Anne Pitkäranta.   

Abstract

OBJECTIVES: To assess upper respiratory surgery rates in Finnish children and compare the rates of adenoidectomy and tympanostomy tubes in 2002 with the 1987 cohort.
METHODS: Descriptive study of national upper respiratory surgery in Finland in 1987 and 2002; adenoidectomies, tympanostomy tubes and combination of these two. Surgical rates were viewed in the light of child density and number of primary care physicians and otorhinolaryngologists.
RESULTS: Rates of adenoidectomy and tympanostomy tubes were highest in Western Finland and lowest in Eastern Finland (p<0.00001). Peak-age for adenoidectomy and tympanostomy tubes was in the second year of life. Surgery was most common in boys (p<0.00001). Both the numbers of otorhinolaryngologists and operations increased from 1987 to 2002; the largest surgery increase, 7.3%, was found in Western Finland.
CONCLUSION: Large national differences in rates of paediatric adenoidectomy and tympanostomy tubes in Finland propose that national guidelines have not had an impact on the selection of children for surgery.

Entities:  

Mesh:

Year:  2006        PMID: 16797731     DOI: 10.1016/j.ijporl.2006.04.005

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  2 in total

1.  Variation in Utilization and Need for Tympanostomy Tubes across England and New England.

Authors:  Devin M Parker; Laura Schang; Jared R Wasserman; Weston D Viles; Gwyn Bevan; David C Goodman
Journal:  J Pediatr       Date:  2016-09-30       Impact factor: 4.406

2.  Variability of adenoidectomy/tonsillectomy rates among children of the Veneto Region, Italy.

Authors:  Ugo Fedeli; Maria Marchesan; Francesco Avossa; Francesco Zambon; Marilisa Andretta; Iacopo Baussano; Paolo Spolaore
Journal:  BMC Health Serv Res       Date:  2009-02-07       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.